In this study, IgG antibody levels—specifically anti-S1 and anti-RBD—showed a consistent increase across all groups of hospitalized COVID-19 patients, reaching a plateau between days 10 and 15, suggesting a robust adaptive immune response to SARS-CoV-2. Here, PSMD1 is linked to COVID-19.